RNA Virus Infections  >>  Recombivax HB (hepatitis B vaccine recombinant)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Recombivax HB (hepatitis B vaccine recombinant) / Merck (MSD)
NCT02040636: Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis

Completed
2
277
Canada
Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV, TdcP-IPV, Hepatitis B vaccine, Recombivax HB®
Sanofi Pasteur, a Sanofi Company
Pertussis, Tetanus, Diphtheria, Poliomyelitis, Hepatitis B
05/00
05/00
NCT00322361 / 2016-003981-15: Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)

Completed
2
566
NA
Comparator: RECOMBIVAX HB™, Comparator: Modified process Hepatitis B Vaccine
Merck Sharp & Dohme LLC
Hepatitis B, Hepatocellular Carcinoma
07/07
07/07

Download Options